Therefore, our research was the first to report the effect of expression levels of GPR68, TKTL1, and SLC16A1 on the prognosis of GBM, and the specific effects of these genes in GBM need to be further confirmed. The gene discussed is SLC16A1; the disease is glioblastoma.